Trials / Completed
CompletedNCT02770326
Safety of Stool Transplant for Patients With Difficult to Treat C. Difficile Infection
Safety of Fecal Microbiota Transplantation (FMT) for Recurrent or Refractory C. Difficile Infection in Patients With Solid Tumors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to test the safety of FMT in patients with C. difficile and cancer. In previous other studies, FMT has been shown to cure C. difficile when antibiotics have failed, but most of these studies have not included patients with cancer. The investigators want to prove that FMT is safe in this group of people so that doctors will feel more comfortable prescribing it for their patients with cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Fecal Microbiota Transplantation (FMT) |
Timeline
- Start date
- 2016-05-10
- Primary completion
- 2024-02-16
- Completion
- 2024-02-16
- First posted
- 2016-05-12
- Last updated
- 2025-04-08
- Results posted
- 2025-04-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02770326. Inclusion in this directory is not an endorsement.